Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:872-875

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, J.
Right arrow Articles by Schlüter, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.
Right arrow Articles by Schlüter, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1999;34:872-875.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Identification of Diadenosine Hexaphosphate in Human Erythrocytes

Jiankai Luo; Joachim Jankowski; Martin Tepel; Markus von der Giet; Walter Zidek; Hartmut Schlüter

From Medizinische Klinik I, Universitäts-Klinik Marienhospital, University of Bochum, Herne, Germany.

Correspondence to Dr Hartmut Schlüter, Medizinische Klinik I, Universitäts-Klinik Marienhospital, der Ruhr-Universität Bochum, Hölkeskampring 40, 44625 Herne, Germany. E-mail Hartmut.Schlueter{at}ruhr-uni-bochum.de

Abstract—Diadenosine polyphosphates have been identified as important regulators of vascular tone and blood pressure. In reference to the background of the well-known vasoconstriction induced by hemolysate, we questioned whether this action may be due in part to the presence of diadenosine polyphosphates in human erythrocytes. Therefore, erythrocytes were separated from other blood cells and deproteinated. To concentrate and purify nucleotides, the extract was chromatographed by anion exchange, affinity, and reversed-phase columns. In one of the purified fractions, diadenosine hexaphosphate (diadenosine 5', 5'-P1, P6 hexaphosphate [AP6A]) was identified by matrix-assisted laser desorption/ionization mass spectrometry, ultraviolet spectroscopy, and enzymatic analysis. Hemolysate of erythrocytes injected into the isolated perfused rat kidney induced a dose-dependent vasoconstriction, which was partially inhibited by P2-purinoceptor antagonist. The data document the existence of AP6A in erythrocytes. AP6A may be involved in the pathogenesis of vasospasm induced by free hemoglobin.


Key Words: diadenosine polyphosphates • erythrocytes • vasoactivity




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Iwai, S. Kuramitsu, and R. Masui
The Nudix Hydrolase Ndx1 from Thermus thermophilus HB8 Is a Diadenosine Hexaphosphate Hydrolase with a Novel Activity
J. Biol. Chem., May 21, 2004; 279(21): 21732 - 21739.
[Abstract] [Full Text] [PDF]